Quality Assessment of Citrus limon (L.) Essential Oils Available on the Turkish Market According to European Pharmacopoeia 10.0 Criteria
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
2630-6344
dc.identifier.doi
10.29228/jгр.2022.00
dc.identifier.other
dc.description.volume
30
dc.description.issue
5
Publisher
MARMARA UNIV, FAC PHARMACY
DOI
10.29228/jгр.2022.00
10.29228/jгр.2022.00
10.29228/jгр.2022.00
Abstract
This study aims to evaluate the compliance of lemon essential oil (LEO) samples available in pharmacies and online platforms in T & uuml;rkiye with European Pharmacopoeia 10.0 (Ph. Eur. 10.0) standards and provide data regarding product quality in the market. Fourteen distinct commercial LEO samples (five from pharmacies and nine from online platforms) were subjected to physicochemical analyses as outlined in the European Pharmacopoeia (EP), including assessments of appearance, relative density, refractive index, optical rotation, and residue on evaporation. The phytochemical profile of the samples was analyzed using gas chromatography-mass spectrometry (GC-MS) and high performance thin layer chromatography (HPTLC) techniques. Products labeled as 100% pure were selected for analysis, and the majority of the analyzed samples failed to meet the EP criteria for key quality attributes. Significant variations detected in the quantities of principal components, such as limonene, citral (neral, geranial), sabinene, and y-terpinene. Only one sample (A5) successfully passed all pharmacopoeial evaluations. Citropene was not detected in the HPTLC analysis across six samples. Sample A1 failed all GC-MS parameters. Furthermore, certain samples revealed fixed oil residue or post-evaporation residues indicative of possible adulterations. No substantial difference was observed between pharmacy and non-pharmacy channels regarding compliance with the pharmacopoeia. The results indicated inadequacies in quality control and non-adherence to pharmacopoeial requirements for lemon essential oil products marketed in T & uuml;rkiye. This circumstance might endanger consumer safety and the possible therapeutic effectiveness of the products. The implementation of quality standards, national reference profiles, and mandated pharmacopoeia analyses might substantially enhance the production of reliable, effective, and verifiable herbal products.
